In conclusion, the metabolismo de lípidos is not a simple tale of fat storage and fuel use. It is an elegantly integrated system of digestion, transport, mitochondrial oxidation, ketone body production, and cytosolic synthesis of fatty acids and cholesterol. These pathways are dynamically tuned by hormonal signals (insulin, glucagon) and energy sensors (AMPK) to maintain metabolic homeostasis. From providing sustained energy during a marathon to building the phospholipid bilayers that define cellular life, from synthesizing steroid hormones to the pathological consequences of their dysregulation—lipid metabolism lies at the very core of human physiology and disease. A deep, mechanistic understanding of these processes is indispensable for developing rational therapies against the modern epidemics of metabolic syndrome and cardiovascular disease. Future research continues to uncover the nuances of lipid signaling, organelle crosstalk, and tissue-specific regulation, promising new targets for therapeutic intervention.
Introduction
When energy demands rise or glucose is scarce (e.g., fasting, exercise), fatty acids become the primary fuel. Hormone-sensitive lipase (HSL) in adipose tissue is activated by glucagon and epinephrine, liberating FFAs into the bloodstream. FFAs, bound to serum albumin, are transported to oxidative tissues like heart, skeletal muscle, and liver. metabolismo de lipideos
When energy and carbohydrate intake exceed immediate needs, the liver and adipose tissue convert excess acetyl-CoA into fatty acids via . This pathway occurs in the cytoplasm. The key regulated enzyme is acetyl-CoA carboxylase (ACC), which converts acetyl-CoA to malonyl-CoA. ACC is activated by citrate (a sign of abundant energy) and insulin, and inhibited by AMPK (energy stress) and glucagon. The fatty acid synthase (FAS) complex, a large multienzyme protein, then uses NADPH (supplied primarily by the pentose phosphate pathway) to extend the malonyl-CoA-derived two-carbon units into palmitate. Further elongation and desaturation (introducing double bonds via desaturases like SCD1) yield the diverse spectrum of cellular fatty acids. In conclusion, the metabolismo de lípidos is not
These newly synthesized fatty acids are esterified to glycerol-3-phosphate to form TAGs for storage. They are also incorporated into membrane phospholipids via the Kennedy pathway or by remodeling existing phospholipids (Lands’ cycle). Cholesterol synthesis (isoprenoid pathway) is another critical anabolic component, beginning with HMG-CoA reductase—the target of statin drugs. Cholesterol is essential for membrane fluidity, lipid rafts, and steroid hormone synthesis. The coordinated regulation of lipogenesis, TAG assembly, and cholesterol synthesis by insulin, SREBP (sterol regulatory element-binding proteins), and ChREBP (carbohydrate response element-binding protein) ensures that excess carbon is stored efficiently. From providing sustained energy during a marathon to
Dysregulation of these pathways underlies major diseases. results from chronic positive energy balance, with hypertrophied adipocytes becoming insulin-resistant and releasing excess FFAs (lipotoxicity). Atherosclerosis is driven by retention of apoB-containing lipoproteins (LDL) in artery walls, where they become oxidized, triggering inflammation and plaque formation. NAFLD arises from ectopic TAG accumulation in the liver due to increased lipogenesis and reduced VLDL export, often in the context of insulin resistance. The carnitine shuttle defects cause hypoketotic hypoglycemia and cardiomyopathy in infants. Understanding these pathways has led to effective therapies: statins (HMG-CoA reductase inhibitors), fibrates (PPAR-α activators that enhance fatty acid oxidation), and emerging inhibitors of ACC or SCD1 for NAFLD.